| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 92,890 shares worth roughly $6.3M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), PCVX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $25.95M | - | |
| CFO | 95.3K | $5.75M | - | |
| Other | 68.1K | $4.11M | - | |
| Other | 52.6K | - | - | |
| COO | 46.4K | - | -20,250 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Wassil Jim53 | EVP, Chief Scientific Ofc, COO | Sale+OE | 18,000 | $86.74 | $1,561,320.00 | -11.0% | - | - | |
| Oct 5, 2026 | Cowan Elvia68 | SVP, Finance &CAO | Sale+OE | 19,000 | $86.74 | $1,648,060.00 | -40.5% | - | - | |
| Oct 1, 2026 | Wassil Jim53 | EVP, Chief Scientific Ofc, COO | Sale+OE | 2,250 | $56.67 | $127,513.30 | -1.5% | - | - | |
| Sep 9, 2026 | Wassil Jim53 | EVP, Chief Scientific Ofc, COO | Sell | 2,715 | $60.35 | $163,862.97 | -1.8% | - | - | |
| Sep 1, 2026 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 3,477 | $61.07 | $212,351.63 | -2.2% | - | - | |
| Aug 5, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sale+OE | 17,000 | $55.00 | $935,068.00 | -18.1% | - | - | |
| Aug 3, 2026 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 2,250 | $53.86 | $121,194.84 | -1.4% | - | - | |
| Aug 3, 2026 | Guggenhime Andrew46 | President And CFO | Sale+OE | 10,000 | $53.89 | $538,879.35 | -8.7% | - | - | |
| Jul 27, 2026 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 18,198 | $55.63 | $1,012,375.29 | -12.0% | - | - | |
| Jul 6, 2026 | Guggenhime Andrew46 | President And CFO | Sale+OE | 10,000 | $57.28 | $572,836.81 | -8.7% | - | - |